Peter Williams appointed General Manager, Incyte Biosciences UK and Ireland

Incyte has announced its appointment of Peter Williams as General Manager for the UK and Ireland division. His new role includes taking charge of the development of medical, regulatory and commercial strategy for the company’s products in the UK and Ireland.
Williams brings 20 years of pharmaceutical experience with him, including having worked as a senior sales and marketing leader, and having held various commercial and senior management roles. He previously worked as senior director for sales and marketing at Gilead Sciences and a business unit director at AbbVie UK. He has demonstrated his industry experience through the creation and development of various business units, along with the launch of some significant medicines in immunology, oncology and haemato-oncology.
Jonathan Dickinson, executive vice president and general manager for Incyte Europe, stated: “On behalf of our leadership team, I would like to welcome Peter to Incyte. His extensive commercial experience will greatly enhance the teams in the UK and Ireland and support our continued growth.”
Commenting on his appointment, Williams said, “Incyte is truly a dynamic company, founded on the premise that following the science and world-class R&D can lead to new solutions poised to positively affect patients’ lives. I am very excited for the opportunity to lead the talented Incyte team here in the UK and Ireland. We have exciting new therapies in our portfolio, and an experienced, growing team, dedicated to the shared goal of ensuring patients have access to important treatments to meet serious unmet medical needs in Oncology and Dermatology.”